相关实验视频

Updated: Jul 2, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

一种基于GD的新型诺米图,用于预测肝细胞癌的预后

Ying Liu¹, Kang Cui¹, Huan Zhao¹

¹Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Frontiers in oncology

|November 29, 2023

概括

一种新的预后标记物,-氨基转化酶 (GGT) 和D-二聚合物 (GD),对预测肝癌存活率显示出希望. 这种GD标志物可以帮助指导肝细胞癌 (HCC) 患者的治疗决策.

科学领域:

肝细胞癌研究肝细胞癌研究
生物标志物发现发现
临床预后临床预后

背景情况:

肝癌的预后仍然很差,需要识别新的预测生物标志物.
准确的预后标记对于指导肝细胞癌 (HCC) 管理中的临床决策至关重要.

研究的目的:

确定和验证肝细胞癌 (HCC) 的新预后标志物.
评估GD标记物的预测价值 (-胺转酶*D-二次体) 对于患者的结果.

主要方法:

对330名无进展生存期 (PFS) 和总生存期 (OS) 数据的HCC患者的回顾性分析.
统计分析包括单变量和多变量分析,卡普兰-梅尔曲线和日志等级测试.
开发和验证一个包含GD标记器的nomogram.

主要成果:

在单变量和多变量分析中,GD标志物与PFS和OS显著相关 (p<0.05).
卡普兰-梅尔曲线显示了基于GD水平的生存率的显著差异 (p<0.001).
纳入GD的名图显示出良好的预测准确性 (C指数0.77/0.76) 和OS的校准.

结论:

GD标志物是HCC的独立预后因素.
这种GD标志物显示出预测HCC患者PFS和OS的潜力.
一个基于GD的诺米图为HCC结果提供了令人满意的预测能力.

关键词:

D-二聚子 D-二聚子谷氨基基透酸酶 (GLTTP) 是一种肝癌肝癌是一种肝癌.这个名字是名ogramogram.预后预后预后预后肝癌肝癌的预后

更多相关视频

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

相关概念视频

Dosage Regimen Designs: Nomograms and Tabulations

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...